Breaking News: AYTU – Market Insights, Analysis & Latest Updates

Filters

Date Range

General Sources

Ambcrypto.com
Cointelegraph.com
Cryptonews.net
Investing.com
Reuters.com
Theblock.co

AYTU

Earnings call: Aytu BioPharma reports turnaround with focus on ADHD

Aytu BioPharma's Q4 FY 2024 highlights strategic focus on ADHD and pediatric therapeutics, with significant EBITDA growth despite challenges and optimism for future revenue growth.

investing.com • 27/09/2024 - 13:25 PM

Greed and Fear Index

Note: The data is for reference only.

Greed

Earnings call: Aytu BioPharma reports turnaround with focus on ADHD

Currency